A dabigatran etexilate solid dispersion enteric-coated preparation and a preparing method thereof
A technology of dabigatran etexilate and solid dispersion, which is applied in the directions of non-active ingredient medical preparations, active ingredients-containing medical preparations, pharmaceutical formulas, etc., can solve problems such as low bioavailability, and achieve inhibition of repolymerization. knot, improve dissolution, and the effect of simple process
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0035] Embodiment 1: preparation of dabigatran etexilate mesylate solid dispersion
[0036] It is 130 ℃ to set the control temperature of the Huck micro mixing rheometer, the screw speed is 40r / min, and the torque is 20N.cm, and the drug dabigatran etexilate and Solupus (polyethylene caprolactam-polyvinyl acetate-polyethylene Glycol graft copolymer) is mixed according to 1:3 and placed in the hopper. After the material is extruded, it is extruded in strips from the film hole of the machine head, cooled at room temperature, crushed, and passed through a 80-mesh sieve to obtain dabigatran ester solid dispersion.
Embodiment 2
[0037] Embodiment 2: the preparation of dabigatran etexilate enteric-coated tablet:
[0038] 300g of dabigatran etexilate solid dispersion prepared in step 1, 20g of low-substituted hydroxypropyl cellulose, 20g of crospovidone, 2g of microcrystalline cellulose, 2g of micropowder silica gel, and an appropriate amount of 5% PVP aqueous solution are prepared After the soft material is passed through a 24-mesh sieve, it is made into granules, pressed into tablets, and used for later use; add gelatin to pure water, heat until the gelatin swells completely, cool down to room temperature, add a plasticizer and stir to dissolve, and obtain a gelatin solution. The tablets are coated, and the coating weight gain is 10%, and 1000 tablets are made to obtain enteric-coated tablets.
Embodiment 3
[0039] Embodiment 3: the preparation of dabigatran etexilate enteric-coated tablet:
[0040] 350g of the dabigatran etexilate solid dispersion prepared in step 1, 50g of low-substituted hydroxypropyl cellulose, 50g of crospovidone, 6g of microcrystalline cellulose, 4g of micropowder silica gel, and an appropriate amount of 5% PVP aqueous solution are prepared After the soft material is passed through a 30-mesh sieve, it is made into granules, pressed into tablets, and used for later use; add gelatin to pure water, heat until the gelatin swells completely, cool down to room temperature, add a plasticizer and stir to dissolve, and obtain a gelatin solution. The tablets are coated, and the coating weight gain is 15%, and 1000 tablets are made to obtain enteric-coated tablets.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com